These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population. Moura RR; Agrelli A; Santos-Silva CA; Silva N; Assunção BR; Brandão L; Benko-Iseppon AM; Crovella S J Clin Pathol; 2021 Aug; 74(8):528-532. PubMed ID: 32759312 [TBL] [Abstract][Full Text] [Related]
4. Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population. Shen Y; Khatri B; Rananaware S; Li D; Ostrov DA; Jain PK; Lessard CJ; Nguyen CQ PLoS One; 2023; 18(1):e0276700. PubMed ID: 36649279 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
6. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002 [TBL] [Abstract][Full Text] [Related]
7. The immunogenetics of COVID-19. Srivastava A; Hollenbach JA Immunogenetics; 2023 Jun; 75(3):309-320. PubMed ID: 36534127 [TBL] [Abstract][Full Text] [Related]
8. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients. Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; López-Ruz MÁ; Martín-Casares AM; Fernández-Rubiales A; Anderson P; Garrido F; Ruiz-Cabello F; López-Nevot MÁ J Microbiol Immunol Infect; 2022 Jun; 55(3):421-427. PubMed ID: 34475005 [TBL] [Abstract][Full Text] [Related]
9. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19. Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK; Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183 [TBL] [Abstract][Full Text] [Related]
11. Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides. Hikichi T; Sakamoto M; Harada M; Saito M; Yamane Y; Tokumura K; Nakamura Y J Hum Genet; 2022 Jul; 67(7):411-419. PubMed ID: 35110673 [TBL] [Abstract][Full Text] [Related]
12. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population. Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837 [TBL] [Abstract][Full Text] [Related]
13. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19. Shkurnikov M; Nersisyan S; Jankevic T; Galatenko A; Gordeev I; Vechorko V; Tonevitsky A Front Immunol; 2021; 12():641900. PubMed ID: 33732261 [TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of the SARS-CoV-2 Infection Profile in COVID-19 Positive Patients in Vitoria da Conquista, Northeast Brazil. Dantas ACS; Oliveira HBM; Gomes CP; Alves DL; Infante PDB; Caitité RJA; Fritsch HM; Cucco MS; Silva LSC; Oliveira CNT; Bittencourt RS; Amorim AT; Nascimento ALP; Marinho FAGC; de Medeiros DS; de Oliveira MGG; Mistro S; de Melo FF; Pereira TTS; Guimarães AMS; Timenetsky J; Moreira PMB; de Oliveira SHP; Alcantara LCJ; Giovanetti M; Santos LA; Fonseca V; Barreto FK; Campos GB; Marques LM Viruses; 2022 Oct; 14(11):. PubMed ID: 36366521 [TBL] [Abstract][Full Text] [Related]
15. Targeted capture enrichment and sequencing identifies HLA variants associated with the severity of COVID-19. Liu C; Zhang L; Chen J; Gao Y Genes Genomics; 2023 Apr; 45(4):451-456. PubMed ID: 36574143 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People. Basir HRG; Majzoobi MM; Ebrahimi S; Noroozbeygi M; Hashemi SH; Keramat F; Mamani M; Eini P; Alizadeh S; Solgi G; Di D Front Immunol; 2022; 13():891816. PubMed ID: 35911710 [TBL] [Abstract][Full Text] [Related]
17. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2. Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS; Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158 [TBL] [Abstract][Full Text] [Related]
18. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463 [TBL] [Abstract][Full Text] [Related]
19. The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection. Hu S; Shao Z; Ni W; Sun P; Qiao J; Wan H; Huang Y; Liu X; Zhai H; Xiao M; Sun B Front Immunol; 2022; 13():919110. PubMed ID: 35874712 [TBL] [Abstract][Full Text] [Related]
20. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil. de Sá NBR; Neira-Goulart M; Ribeiro-Alves M; Perazzo H; Geraldo KM; Ribeiro MPD; Cardoso SW; Grinsztejn B; Veloso VG; Capão A; Siqueira MM; de Lima Bezerra OC; Garcia CC; Gomes LR; da Silva Cazote A; de Almeida DV; Giacoia-Gripp CBW; Côrtes FH; Morgado MG Biomed Res Int; 2022; 2022():9082455. PubMed ID: 36105941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]